130 related articles for article (PubMed ID: 3081427)
1. Interindividual differences in the activation of two hepatic carcinogens to mutagens by human liver.
Harries GC; Boobis AR; Collier N; Davies DS
Hum Toxicol; 1986 Jan; 5(1):21-6. PubMed ID: 3081427
[TBL] [Abstract][Full Text] [Related]
2. Modified mutagen metabolism in Schistosoma hematobium-infested organisms.
Gentile JM; Brown S; Aardema M; Clark D; Blankespoor H
Arch Environ Health; 1985; 40(1):5-12. PubMed ID: 3922319
[TBL] [Abstract][Full Text] [Related]
3. Effect of liver S9 from 3,4,5,3',4'-pentachlorobiphenyl-pretreated rats on the mutagenic activity of the various carcinogens toward Salmonella typhimurium TA 98.
Ozawa N; Watabe T; Yoshimura H; Koga N; Shudo K
J Pharmacobiodyn; 1985 Mar; 8(3):199-205. PubMed ID: 3925118
[TBL] [Abstract][Full Text] [Related]
4. Differences in response of glucuronide and glutathione conjugating enzymes to aflatoxin B1 and N-acetylaminofluorene in underfed rats.
Rajpurohit R; Krishnaswamy K
J Toxicol Environ Health; 1988; 24(1):103-9. PubMed ID: 3131540
[TBL] [Abstract][Full Text] [Related]
5. Comparison of metabolic activation of carcinogens in human, rat, and hamster hepatocytes.
Synder S; Hsu IC; Trump BF
Mutat Res; 1987 Feb; 182(1):31-9. PubMed ID: 3100948
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of benzo[a]pyrene, aflatoxin B1, and dimethylnitrosamine by a human hepatoma cell line.
Huh N; Nemoto N; Utakoji T
Mutat Res; 1982 Jun; 94(2):339-48. PubMed ID: 6287253
[TBL] [Abstract][Full Text] [Related]
7. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
[TBL] [Abstract][Full Text] [Related]
8. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene.
Rudo K; Meyers WC; Dauterman W; Langenbach R
Cancer Res; 1987 Nov; 47(22):5861-7. PubMed ID: 2822235
[TBL] [Abstract][Full Text] [Related]
9. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
Yourtee DM; Kirk-Yourtee CL
Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
[TBL] [Abstract][Full Text] [Related]
10. Promutagen activation in partially hepatectomized mice.
Vandewaa EA; Barney CC; Gentile JM
Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
[TBL] [Abstract][Full Text] [Related]
11. Influence of mouse liver stored vitamin A on the induction of mutations (Ames tests) and SCE of bone marrow cells by aflatoxin B1, benzo(a)pyrene, or cyclophosphamide.
Qin S; Huang CC
Environ Mutagen; 1986; 8(6):839-47. PubMed ID: 3096708
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of carcinogens in the Salmonella mutagenicity assay by hamster and rat liver S-9 preparations.
Raineri R; Poiley JA; Pienta RJ; Andrews AW
Environ Mutagen; 1981; 3(1):71-84. PubMed ID: 7021144
[No Abstract] [Full Text] [Related]
13. Mutagenic activation of aflatoxin B1 by several forms of purified cytochrome P-450.
Ishii K; Maeda K; Kamataki T; Kato R
Mutat Res; 1986 Jun; 174(2):85-8. PubMed ID: 3086716
[TBL] [Abstract][Full Text] [Related]
14. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.
Aoyama T; Yamano S; Guzelian PS; Gelboin HV; Gonzalez FJ
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4790-3. PubMed ID: 2162057
[TBL] [Abstract][Full Text] [Related]
15. Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens.
Cassand P; Leveque F; Decoudu S; Narbonne JF
Food Addit Contam; 1990; 7 Suppl 1():S58-9. PubMed ID: 2124552
[No Abstract] [Full Text] [Related]
16. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver.
Forrester LM; Neal GE; Judah DJ; Glancey MJ; Wolf CR
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8306-10. PubMed ID: 2122459
[TBL] [Abstract][Full Text] [Related]
17. Identification and mutagenicity of aflatoxicol-M1 produced by metabolism of aflatoxin B1 and aflatoxicol by liver fractions from rainbow trout (Salmo gairdneri) fed beta-naphthoflavone.
Loveland PM; Coulombe RA; Libbey LM; Pawlowski NE; Sinnhuber RO; Nixon JE; Bailey GS
Food Chem Toxicol; 1983 Oct; 21(5):557-62. PubMed ID: 6418626
[TBL] [Abstract][Full Text] [Related]
18. Specificity of hepatic cytochrome P-450 isoenzymes from PCB-treated rats and participation of cytochrome b5 in the activation of aflatoxin B1.
Ueno Y; Ishii K; Omata Y; Kamataki T; Kato R
Carcinogenesis; 1983 Aug; 4(8):1071-3. PubMed ID: 6409444
[TBL] [Abstract][Full Text] [Related]
19. Detoxification of genotoxic compounds as a threshold mechanism limiting their carcinogenicity.
De Flora S
Toxicol Pathol; 1984; 12(4):337-43. PubMed ID: 6442795
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in mutagen activation by rat tissues.
Robertson IG; Birnbaum LS
Chem Biol Interact; 1982 Jan; 38(2):243-52. PubMed ID: 6799214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
